Cabozantinib Boosts Dual Immunotherapy in Advanced RCC
Triplet therapy for advanced renal cell carcinoma may soon be an option, after results show that adding cabozantinib to dual immune checkpoint inhibition improved progression-free survival.
Stay updated with breaking news from Watch Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Triplet therapy for advanced renal cell carcinoma may soon be an option, after results show that adding cabozantinib to dual immune checkpoint inhibition improved progression-free survival.
The field of osteopathy is growing, and so is respect for what it can offer healthcare.
Sodium glucose cotransporter 2 inhibitors (SGLT2is) lowered the risk of nonalcoholic fatty liver disease and hapatocellular carcinoma versus dipeptidyl-peptidase-4 inhibitors (DPP4is).
The National Resident Matching Program is seeking input on a plan to replace the current system with the goal of improving the application and interview review period.
Special permits for unmatched med students may help fill a gap in the path to residency, especially for international graduates, but debate continues as to whether it's an effective, long-term solution.